We are pleased to share the latest article co-authored by our Main Principal Investigator (PI), Dr. Katarzyna Romanowska-Próchnicka, MD, PhD. The article has just been published in Annals of the Rheumatic Diseases, one of the world’s most prestigious scientific journals in the field of rheumatology.
The study described in the article was conducted at one of our Clinical Research Centers in Warsaw.
Article title:
B-cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment.
Congratulations to Dr. Romanowska-Próchnicka and the entire research team on the recognition of their work through publication in a highly regarded scientific journal, as well as on the successful conduct of the study at our Warsaw site.
**
Dr. Katarzyna Romanowska-Próchnicka graduated from the Medical University of Warsaw. In 2014, she defended her PhD with distinction, focusing on osteoimmunological mechanisms in rheumatoid arthritis. She holds specializations in internal medicine and rheumatology and is an Assistant Professor at the Department of Biophysics, Physiology and Pathophysiology at the Medical University of Warsaw. She is a Principal Investigator in numerous academic and commercial studies related to autoimmune diseases.
